IP Library Granted Patent US 9,018,220
Granted Patent B2
US 9,018,220 · App. 13/967,629 · Granted Apr 28, 2015

Mesoionic pesticides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,018,220
App. No.
13/967,629
Granted
Apr 28, 2015
Kind
B2
Abstract

Disclosed are compounds of Formula 1, wherein X is O or S; Y is O or S; and R 1 , R 2 , R 3 and R 4 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.

Claims (38)

1. A compound of Formula 1,

wherein

X is O;

Y is O;

R 1 is phenyl or a 6-membered heteroaromatic ring, each optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkylcarbonyl, C 2 -C 4 haloalkylcarbonyl, C 2 -C 4 alkoxycarbonyl, C 2 -C 4 alkylaminocarbonyl, C 3 -C 7 dialkylaminocarbonyl, C(O)N CH 2 Z 2 CH 2 , C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 2 -C 6 alkoxyalkyl, S(O) n R 12 , S(O) 2 R 13 , C 1 -C 4 alkylamino, C 2 -C 6 dialkylamino, SF 5 , Si(CH 3 ) 3 , CHO, hydroxy, OC(O)R 19 and N(R 20 )C(O)R 19 ;

R 2 is C 2 -C 6 alkyl, C 1 -C 6 haloalkyl or CR 5 R 6 CH 2 OR 21 ; or

R 2 is C 4 -C 7 cycloalkylalkyl optionally substituted with 1 to 4 substituents selected from the group consisting of halogen, C 1 -C 2 alkyl, 1 cyclopropyl and 1CF 3 ;

R 3 and R 4 are taken together with the contiguous linking nitrogen and carbon atoms to form an optionally substituted ring R-2

Z is C(R 8a )═C(R 8b ), provided that the C(R 8a )═C(R 8b ) moiety is oriented so the carbon atom bonded to R 8b is connected as R 3 in Formula 1;

each R 5 is independently H, F, Cl, cyano or C 1 -C 4 alkyl;

each R 6 is independently H, F, Cl or CH 3 ;

R 8a is H;

R 8b is H or F;

each R 12 is independently C 1 -C 4 alkyl or C 1 -C 4 haloalkyl;

each R 13 is independently C 1 -C 4 alkylamino, C 2 -C 6 dialkylamino or —N CH 2 Z 2 CH 2 ;

each R 19 is independently C 1 -C 4 alkyl;

each R 20 is independently H or C 1 -C 4 alkyl;

each R 21 is independently H or C 1 -C 4 alkyl;

each n is independently 0, 1 or 2; and

each Z 2 is independently CH 2 CH 2 , CH 2 CH 2 CH 2 or CH 2 OCH 2 .

2. The compound of claim 1 wherein

R 1 is phenyl or pyridinyl, each optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkylcarbonyl, C 2 -C 4 haloalkylcarbonyl, C 2 -C 4 alkoxycarbonyl, C 2 -C 4 alkylaminocarbonyl, C 3 -C 7 dialkylaminocarbonyl, C(O)N CH 2 Z 2 CH 2 , C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, C 2 -C 6 alkoxyalkyl, S(O) n R 12 , S(O) 2 R 13 , C 1 -C 4 alkylamino, C 2 -C 6 dialkylamino, SF 5 , Si(CH 3 ) 3 , CHO, hydroxy, OC(O)R 19 and N(R 20 )C(O)R 19 .

3. The compound of claim 2 wherein

each R 5 is independently H or C 1 -C 4 alkyl.

4. The compound of claim 3 wherein

each R 5 is independently H or methyl.

5. The compound of claim 4 wherein

R 6 is H.

6. The compound of claim 1 that is selected from the group consisting of

3-(2,4-difluorophenyl)-2-hydroxy-4-oxo-1-(2,2,2-trifluoroethyl)-4H-pyrido[1,2-a]pyrimidinium inner salt;

3-(4-fluorophenyl)-2-hydroxy-4-oxo-1-(2,2,2-trifluoroethyl)-4H-pyrido[1,2-a]pyrimidinium inner salt; and

2-hydroxy-4-oxo-3-phenyl-1-(2,2,2-trifluoroethyl)-4H-pyrido[1,2-a]pyrimidinium inner salt.

7. A composition comprising a compound of claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent.

8. The composition of claim 7 wherein the at least one additional Biologically active compound or agent is selected from the group consisting of abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, bistrifluoron, borate, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide (cyantraniliprole), buprofezin, cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clofentezin, clothianidin, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin,zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, flufenerim, flufenoxuron, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methiodicarb, methomyl, methoprene, methoxychlor, metofluthrin, monocrotophos, methoxyfenozide, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulprofos, sulfoxaflor, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumuron, Bacillus thuringiensis delta-endotoxins, entomopathogenic bacteria, entomopathogenic viruses and entomopathogenic fungi.

9. The composition of claim 8 wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acetamiprid, acrinathrin, amitraz, avermectin, azadirachtin, bifenthrin, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide (cyantraniliprole), buprofezin, cadusafos, carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenothiocarb, fenoxycarb, fenvalerate, fipronil, flonicamid, flubendiamide, flufenoxuron, fluvalinate, formetanate, fosthiazate, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, lufenuron, metaflumizone, methiodicarb, methomyl, methoprene, methoxyfenozide, nitenpyram, nithiazine, novaluron, oxamyl, pymetrozine, pyrethrin, pyridaben, pyridalyl, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, tebufenozide, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumuron, Bacillus thuringiensis delta-endotoxins, all strains of Bacillus thuringiensis and all strains of Nucleo polyhydrosis viruses.

10. A composition for protecting an animal from an invertebrate parasitic pest comprising a parasiticidally effective amount of a compound of claim 1 and at least one carrier.

11. A method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of claim 1 .

12. A treated seed comprising a compound of claim 1 in an amount of from 0.0001 to 1% by weight of the seed before treatment.

Assignments (3)
PATENT SECURITY AGREEMENT Recorded Apr 17, 2026
From: FMC CORPORATION
To: CITIBANK, N.A.
Reel/Frame 075403/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2018
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: FMC CORPORATION
Reel/Frame 046732/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2013
From: HOLYOKE, CALEB WILLIAM, JR; ZHANG, WENMING
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 031597/0406 →